APO RESEARCH · REPORT
Platinum based Cancer Drug
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Product & engineering
Understand the product.
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Selected research
Industry Research
Platinum based Cancer Drug Industry Research Report 2026
Market perspective
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Read the full market overview
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Report Scope
This report quantifies the global Platinum based Cancer Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Platinum based Cancer Drug Market by Company
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Platinum based Cancer Drug Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others
Platinum based Cancer Drug Segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Platinum based Cancer Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Platinum based Cancer Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cisplatin
- Oxaliplatin
- Carboplatin
- Others
Applications
- Colorectal Cancer
- Ovarian Cancer
- Lung Cancer
- Others
Companies covered
- Sanofi
- Hengrui Medicine
- ASK Pharma
- Yi Bai Pharmaceutical
- Qilu Pharmaceutical
- Teva
- Pfizer
- Dr Reddy's Laboratories
- Mylan
- Sun Pharma
- Novartis
- Debiopharm
- Accord Healthcare
- SK Chemicals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Platinum based Cancer Drug Market Size (2021-2032)
- 2.2.2 Global Platinum based Cancer Drug Sales (2021-2032)
- 2.2.3 Global Platinum based Cancer Drug Market Average Price (2021-2032)
- 2.3 Platinum based Cancer Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cisplatin
- 2.3.3 Oxaliplatin
- 2.3.4 Carboplatin
- 2.3.5 Others
- 2.4 Platinum based Cancer Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Colorectal Cancer
- 2.4.3 Ovarian Cancer
- 2.4.4 Lung Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Platinum based Cancer Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Platinum based Cancer Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Platinum based Cancer Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Platinum based Cancer Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Platinum based Cancer Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Platinum based Cancer Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Platinum based Cancer Drug, Product Type & Application
- 3.8 Global Manufacturers of Platinum based Cancer Drug, Established Date
- 3.9 Global Platinum based Cancer Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Hengrui Medicine
- 4.2.1 Hengrui Medicine Company Information
- 4.2.2 Hengrui Medicine Business Overview
- 4.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
- 4.2.5 Hengrui Medicine Recent Developments
- 4.3 ASK Pharma
- 4.3.1 ASK Pharma Company Information
- 4.3.2 ASK Pharma Business Overview
- 4.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
- 4.3.5 ASK Pharma Recent Developments
- 4.4 Yi Bai Pharmaceutical
- 4.4.1 Yi Bai Pharmaceutical Company Information
- 4.4.2 Yi Bai Pharmaceutical Business Overview
- 4.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
- 4.4.5 Yi Bai Pharmaceutical Recent Developments
- 4.5 Qilu Pharmaceutical
- 4.5.1 Qilu Pharmaceutical Company Information
- 4.5.2 Qilu Pharmaceutical Business Overview
- 4.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
- 4.5.5 Qilu Pharmaceutical Recent Developments
- 4.6 Teva
- 4.6.1 Teva Company Information
- 4.6.2 Teva Business Overview
- 4.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva Platinum based Cancer Drug Product Portfolio
- 4.6.5 Teva Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Dr Reddy's Laboratories
- 4.8.1 Dr Reddy's Laboratories Company Information
- 4.8.2 Dr Reddy's Laboratories Business Overview
- 4.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
- 4.8.5 Dr Reddy's Laboratories Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Platinum based Cancer Drug Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 Sun Pharma
- 4.10.1 Sun Pharma Company Information
- 4.10.2 Sun Pharma Business Overview
- 4.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
- 4.10.5 Sun Pharma Recent Developments
- 4.11 Novartis
- 4.11.1 Novartis Company Information
- 4.11.2 Novartis Business Overview
- 4.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novartis Platinum based Cancer Drug Product Portfolio
- 4.11.5 Novartis Recent Developments
- 4.12 Debiopharm
- 4.12.1 Debiopharm Company Information
- 4.12.2 Debiopharm Business Overview
- 4.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
- 4.12.5 Debiopharm Recent Developments
- 4.13 Accord Healthcare
- 4.13.1 Accord Healthcare Company Information
- 4.13.2 Accord Healthcare Business Overview
- 4.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
- 4.13.5 Accord Healthcare Recent Developments
- 4.14 SK Chemicals
- 4.14.1 SK Chemicals Company Information
- 4.14.2 SK Chemicals Business Overview
- 4.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
- 4.14.5 SK Chemicals Recent Developments
5 Global Platinum based Cancer Drug Market Scenario by Region
- 5.1 Global Platinum based Cancer Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Platinum based Cancer Drug Sales by Region: 2021-2032
- 5.2.1 Global Platinum based Cancer Drug Sales by Region: 2021-2026
- 5.2.2 Global Platinum based Cancer Drug Sales by Region: 2027-2032
- 5.3 Global Platinum based Cancer Drug Revenue by Region: 2021-2032
- 5.3.1 Global Platinum based Cancer Drug Revenue by Region: 2021-2026
- 5.3.2 Global Platinum based Cancer Drug Revenue by Region: 2027-2032
- 5.4 North America Platinum based Cancer Drug Market Facts & Figures by Country
- 5.4.1 North America Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Platinum based Cancer Drug Sales by Country (2021-2032)
- 5.4.3 North America Platinum based Cancer Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Platinum based Cancer Drug Market Facts & Figures by Country
- 5.5.1 Europe Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Platinum based Cancer Drug Sales by Country (2021-2032)
- 5.5.3 Europe Platinum based Cancer Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Platinum based Cancer Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Platinum based Cancer Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Platinum based Cancer Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Platinum based Cancer Drug Market Facts & Figures by Country
- 5.7.1 South America Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Platinum based Cancer Drug Sales by Country (2021-2032)
- 5.7.3 South America Platinum based Cancer Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Platinum based Cancer Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Platinum based Cancer Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Platinum based Cancer Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Platinum based Cancer Drug Sales by Type (2021-2032)
- 6.1.1 Global Platinum based Cancer Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Platinum based Cancer Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Platinum based Cancer Drug Revenue by Type (2021-2032)
- 6.2.1 Global Platinum based Cancer Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Platinum based Cancer Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Platinum based Cancer Drug Sales by Application (2021-2032)
- 7.1.1 Global Platinum based Cancer Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Platinum based Cancer Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Platinum based Cancer Drug Revenue by Application (2021-2032)
- 7.2.1 Global Platinum based Cancer Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Platinum based Cancer Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Platinum based Cancer Drug Value Chain Analysis
- 8.1.1 Platinum based Cancer Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Platinum based Cancer Drug Production Mode & Process
- 8.2 Platinum based Cancer Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Platinum based Cancer Drug Distributors
- 8.2.3 Platinum based Cancer Drug Customers
9 Global Platinum based Cancer Drug Analyzing Market Dynamics
- 9.1 Platinum based Cancer Drug Industry Trends
- 9.2 Platinum based Cancer Drug Industry Drivers
- 9.3 Platinum based Cancer Drug Industry Opportunities and Challenges
- 9.4 Platinum based Cancer Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst